相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women
Annalene A. Nel et al.
AIDS (2009)
Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor
P. Fletcher et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Drug-resistant human immunodefiency virus
M. J. Kozal
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Cell-mediated immunity to HIV in the female reproductive tract
Barbara L. Shacklett
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2009)
Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection
Jiri Mestecky et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2009)
Microbicide delivery: formulation technologies and strategies
Joseph Romano et al.
CURRENT OPINION IN HIV AND AIDS (2008)
Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days
Jeremy P. Nuttall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Safety, tolerance and acceptability of the Invisible Condom®, and its vaginal applicator in healthy women and their male sexual partners
Sylvie Trottier et al.
CONTRACEPTION (2007)
Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers
Vicky A. Jespers et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide
A. David Woolfson et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Safety and acceptability of the candidate microbicide Carraguard in Thai women: Findings from a phase II clinical trial
Peter H. Kilmarx et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women
KH Mayer et al.
AIDS (2006)
Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?
Jorge Martinez et al.
ANTIVIRAL RESEARCH (2006)
Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel
IM Malonza et al.
AIDS (2005)
Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings
RK Malcolm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Acceptability of a microbicide among women and their partners in a 4-country phase I trial
ME Bentley et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2004)
Clinical development of microbicides for the prevention of HIV infection
OJ D'Cruz et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides
Y Van Herrewege et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The acceptability of an investigational vaginal microbicide, PRO 2000 gel, among women in a phase I clinical trial
K Morrow et al.
JOURNAL OF WOMENS HEALTH (2003)
Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation
S Di Fabio et al.
AIDS (2003)
分享论文
